NEW YORK and MONTREAL, July 21 /PRNewswire-FirstCall/ - BioSpec Global Solutions Inc., and partner -ICBS Ltd. (OTCPK: ICBT), announced today that the company has entered into talks with a new possible Chinese partner.
"China is one of the world's largest markets for our analyzer's and has one of the worst water situations on the planet" said Don Saunders President and CEO of BioSpec Global Solutions. We have made contact with a new possible Chinese partner. The unnamed party has entered into preliminary talks with BGS that would see BGS make a quicker entry into the lucrative Chinese market.
The company is in production of the TOG's 3000 which will lead the market development in China. However should the company sign with the unnamed partner the company could see manufacturing shift to China. BioSpec Global Solutions, has developed the TOGS 3000 to analyze total bacterial count in water samples. Given the advantages not only on time advantage (24 Hours for test results) but the accuracy of these machines, can equip agencies with the technology needed to insure safe drinking water for their citizens.
BioSpec Global Solutions Inc., has a non-exclusive agreement with Beijing Titan Instruments co.
Verification studies for the TOGS(TM) 9000 has been completed by Ryerson University and the instrument has, like the Pro3000(TM), been accepted by the EPA in the USA for use in presence absence testing of drinking water when used with an EPA approved method and reagent. The TOGS(TM)9000 has been used by the United Nation for a emergency relief project in the Dominican Republic. A verification study by Michigan State University, an EPA laboratory, is ongoing for viruses. Further verification and validation studies will be done shortly by users and ETV (Environmental Technology Verification) for microbial quantification for beach and wastewater applications.
The company holds worldwide patents on the TOGS 3000 and 9000.
NB. This news release includes statements that constitute forward-looking statements. Please be aware that any such forward-looking statements are not guarantees of future performance and involve significant risks and uncertainties, and that actual results may vary materially from those in the forward-looking statements as a result of any number of factors, including the risk factors contained in the Company's disclosure documents.
|SOURCE BioSpec Global Solutions Inc.|
Copyright©2010 PR Newswire.
All rights reserved